Literature DB >> 9371523

Renal cell carcinoma: recent progress and future directions.

P Mulders1, R Figlin, J B deKernion, R Wiltrout, M Linehan, D Parkinson, W deWolf, A Belldegrun.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9371523

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  21 in total

1.  Dietary Inflammatory Index and Renal Cell Carcinoma Risk in an Italian Case-Control Study.

Authors:  Nitin Shivappa; James R Hébert; Valentina Rosato; Marta Rossi; Maurizio Montella; Diego Serraino; Carlo La Vecchia
Journal:  Nutr Cancer       Date:  2017-07-18       Impact factor: 2.900

2.  Flaws in the peer-reviewing process : a critical look at a recent paper studying the role of CCN3 in renal cell carcinoma.

Authors:  Bernard Perbal
Journal:  J Cell Commun Signal       Date:  2012-08-03       Impact factor: 5.782

3.  Liver resection for metastases from renal cell carcinoma.

Authors:  Armin Thelen; S Jonas; C Benckert; E Lopez-Hänninen; B Rudolph; U Neumann; P Neuhaus
Journal:  World J Surg       Date:  2007-04       Impact factor: 3.352

4.  RNA interference-directed caveolin-1 knockdown sensitizes SN12CPM6 cells to doxorubicin-induced apoptosis and reduces lung metastasis.

Authors:  Juwon Park; Eunkyung Bae; Chansu Lee; Sung-Soo Yoon; Yang Seok Chae; Kwang-Sung Ahn; Nam Hee Won
Journal:  Tumour Biol       Date:  2010-09-04

5.  CA9 gene expression in conventional renal cell carcinoma: a potential marker for prediction of early metastasis after nephrectomy.

Authors:  Guorong Li; Gang Feng; Anne Gentil-Perret; Christian Genin; Jacques Tostain
Journal:  Clin Exp Metastasis       Date:  2007-03-28       Impact factor: 5.150

6.  Laparoscopic adrenalectomy for metachronous metastasis from renal cell carcinoma.

Authors:  Stéphane Bonnet; Sébastien Gaujoux; Mahaut Leconte; Jean-Marc Thillois; Frédérique Tissier; Bertrand Dousset
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

7.  A randomized phase III trial of high dose interleukin-2 versus subcutaneous interleukin-2/interferon.

Authors:  Ken-Ryu Han; Allan J Pantuck; Arie S Belldegrun
Journal:  Curr Urol Rep       Date:  2002-02       Impact factor: 3.092

8.  Significance of serum tumor necrosis factor-related apoptosis-inducing ligand as a prognostic biomarker for renal cell carcinoma.

Authors:  Daisuke Toiyama; Natsuki Takaha; Masahide Shinnoh; Takashi Ueda; Yasunori Kimura; Terukazu Nakamura; Fumiya Hongo; Kazuya Mikami; Kazumi Kamoi; Akihiro Kawauchi; Tsuneharu Miki
Journal:  Mol Clin Oncol       Date:  2012-10-15

9.  LncRNA LINC00944 Promotes Tumorigenesis but Suppresses Akt Phosphorylation in Renal Cell Carcinoma.

Authors:  Chiheng Chen; Hanxiong Zheng
Journal:  Front Mol Biosci       Date:  2021-07-05

Review 10.  The role of adjuvant immunotherapy in renal cell carcinoma.

Authors:  Peter F A Mulders; Pieter H M De Mulder
Journal:  Curr Urol Rep       Date:  2002-02       Impact factor: 2.862
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.